General MedicationsINJECTIONGeneric
DEXAMETHASONE ACETATE
DEXAMETHASONE ACETATE
Standard Dose
EQ 8MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DEXAMETHASONE ACETATE is listed in Drugs@FDA under application 084315 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE ACETATE Form and strength INJECTABLE;INJECTION - EQ 8MG BASE/ML Sponsor WATSON LABS Submission history Latest submission status date: 2014-12-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview DEXAMETHASONE ACETATE is listed in Drugs@FDA under application 084315 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE ACETATE Form and strength INJECTABLE;INJECTION - EQ 8MG BASE/ML Sponsor WATSON LABS Submission history Latest submission status date: 2014-12-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.